Copyright
©The Author(s) 2025.
World J Hepatol. Apr 27, 2025; 17(4): 98660
Published online Apr 27, 2025. doi: 10.4254/wjh.v17.i4.98660
Published online Apr 27, 2025. doi: 10.4254/wjh.v17.i4.98660
Table 1 Evolution of hepatitis B surface antigen before and after liver transplantation for both patients
HBsAg | Case 1 | Case 2 |
Before LT | + | + |
1st week after LT | + | + |
2nd week after LT | - | + |
8th week after LT | - | + |
24th week after LT | - | + |
36th week after LT | - | - |
Table 2 Hepatitis B virus serological markers before liver transplantation for both patients
Preoperative exams | Case 1 | Case 2 |
HBsAg | + | + |
Anti-HBs | UR | - |
HBeAg | UR | - |
Anti-HBe | UR | UR |
Anti-HBc | UR | + |
Viral load | - | + |
- Citation: Ortiz-López N, Acevedo M, Vergara T, Roblero JP, Urzúa Á, Cattaneo M, Poniachik J. Dual therapy with nucleos(t)ide analogues in the prevention of hepatitis B virus recurrence after liver transplantation: Two case reports. World J Hepatol 2025; 17(4): 98660
- URL: https://www.wjgnet.com/1948-5182/full/v17/i4/98660.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i4.98660